Just going back to Dank's first post on this thread.
This study is very, very exciting. And if you go to the original article you will see that Professor Mark Kay is one of the researchers. Mark Kay is one of the original developers of the minicircle technology and a one time scientific consultant to BLT. BLT now own the exclusive rights to this technology.
The recent Chinese news articles referring to the pain program, talk of the involvement of Stanford University, where Mark Kay is based and mentions one of his phd researchers specifically. I am just wondering if the sudden involvement of Stanford Uni in BLT's pain program also has a lot to do with advancing this minicircle research.
It's probably just wishful thinking on my part, but it seems kind of a coincidence, don't you think?
- Forums
- ASX - By Stock
- BLT
- in-vivo non-viral delivery of shrna for mi
in-vivo non-viral delivery of shrna for mi, page-7
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online